Onesource Specialty Pharma Limited · NSE: ONESOURCE · BSE: 544292

Onesource Specialty Pharma

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 24 Jul 2026.

Q1 FY27 · Consolidated

Revenue
449.02₹ Cr
+37.2% vs year ago
Net profit
25.00₹ Cr
Turned profit vs year ago
EPS, basic
2.18₹
Turned profit vs year ago
Net margin
5.6%
+5.6 pts vs year ago
Revenue₹ crore · consolidated · last 8 quarters
Q2 FY25: ₹67.98 CrQ3 FY25: ₹392.56 CrQ4 FY25: ₹425.95 CrQ1 FY26: ₹327.27 CrQ2 FY26: ₹375.76 CrQ3 FY26: ₹290.34 CrQ4 FY26: ₹428.22 CrQ1 FY27: ₹449.02 CrQ3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 8 quarters
Q2 FY25: ₹(39.33) CrQ3 FY25: ₹(68.85) CrQ4 FY25: ₹98.20 CrQ1 FY26: ₹(0.19) CrQ2 FY26: ₹10.48 CrQ3 FY26: ₹(88.70) CrQ4 FY26: ₹4.60 CrQ1 FY27: ₹25.00 CrQ3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026449.02+37.2%25.00Turned profit2.1824 Jul 2026
Q4 FY26Jan–Mar 2026428.22+0.5%4.60−95.3%0.4013 May 2026
Q3 FY26Oct–Dec 2025290.34−26.0%(88.70)Loss widened(7.74)23 Jan 2026
Q2 FY26Jul–Sep 2025375.76+452.8%10.48Turned profit0.9211 Nov 2025
Q1 FY26Apr–Jun 2025327.27—(0.19)—(0.02)04 Aug 2025
Q4 FY25Jan–Mar 2025425.95—98.20—8.6105 May 2025
Q3 FY25Oct–Dec 2024392.56—(68.85)—(6.31)29 Jan 2025
Q2 FY25Jul–Sep 202467.98—(39.33)—(18.82)28 Jan 2025
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026446.47+39.1%51.23+106.4%4.4724 Jul 2026
Q4 FY26Jan–Mar 2026418.96−12.2%21.48−87.7%1.8713 May 2026
Q3 FY26Oct–Dec 2025290.22−13.8%(62.19)Loss narrowed(5.43)23 Jan 2026
Q2 FY26Jul–Sep 2025375.19+451.9%37.10Turned profit3.2411 Nov 2025
Q1 FY26Apr–Jun 2025321.01—24.82—2.1704 Aug 2025
Q4 FY25Jan–Mar 2025477.41—174.19—15.2805 May 2025
Q3 FY25Oct–Dec 2024336.75—(73.02)—(6.69)29 Jan 2025
Q2 FY25Jul–Sep 202467.98—(40.02)—(19.26)28 Jan 2025

16 filings on record for this company.